134 related articles for article (PubMed ID: 15856296)
1. Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma.
Nakatani K; Wada T; Nakamura M; Uzawa K; Tanzawa H; Fujita S
J Cancer Res Clin Oncol; 2005 Jul; 131(7):445-52. PubMed ID: 15856296
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R.
Nakamura M; Nakatani K; Uzawa K; Ono K; Uesugi H; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Wada T; Fujita S; Tanzawa H
Oncol Rep; 2005 Nov; 14(5):1281-6. PubMed ID: 16211297
[TBL] [Abstract][Full Text] [Related]
3. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
4. Establishment and gene analysis of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma.
Nakatani K; Nakamura M; Uzawa K; Wada T; Seki N; Tanzawa H; Fujita S
Oncol Rep; 2005 Apr; 13(4):709-14. PubMed ID: 15756446
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
7. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
[TBL] [Abstract][Full Text] [Related]
9. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.
Yamasaki M; Makino T; Masuzawa T; Kurokawa Y; Miyata H; Takiguchi S; Nakajima K; Fujiwara Y; Matsuura N; Mori M; Doki Y
Br J Cancer; 2011 Feb; 104(4):707-13. PubMed ID: 21206495
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
[TBL] [Abstract][Full Text] [Related]
11. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells.
Yamano Y; Shiiba M; Negoro K; Nakatani K; Kasamatsu A; Yamatoji M; Sakuma K; Ogoshi K; Iyoda M; Shinozuka K; Yokoe H; Wada T; Fujita S; Iwasawa S; Takiguchi Y; Tanzawa H; Uzawa K
Head Neck; 2011 Mar; 33(3):309-17. PubMed ID: 20848452
[TBL] [Abstract][Full Text] [Related]
13. ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells.
Torii Y; Kato R; Minami Y; Hasegawa K; Fujii T; Udagawa Y
Anticancer Res; 2014 Jan; 34(1):107-15. PubMed ID: 24403450
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP].
Zhou XJ; Li Q; Chen WT
Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583
[TBL] [Abstract][Full Text] [Related]
15. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
16. Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
Shen LY; Wang H; Dong B; Yan WP; Lin Y; Shi Q; Chen KN
Oncotarget; 2016 Jan; 7(4):4531-41. PubMed ID: 26673820
[TBL] [Abstract][Full Text] [Related]
17. [The histological antitumor effect and side effects of preoperative chemotherapy for patients with oral squamous cell carcinoma--comparison between low-dose and high-dose CDDP regimens].
Nakazawa M; Iwai S; Moriyama T; Kato I; Uekusa Y; Katagiri W; Takeuchi N; Matsumoto K; Sakuda M
Gan To Kagaku Ryoho; 2001 Mar; 28(3):337-43. PubMed ID: 11265401
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
[TBL] [Abstract][Full Text] [Related]
19. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma.
Nakano M; Sogawa CA; Sogawa N; Mishima K; Yamachika E; Mizukawa N; Fukunaga J; Kawamoto T; Sawaki K; Sugahara T; Furuta H
Anticancer Res; 2003; 23(1A):299-303. PubMed ID: 12680227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
